|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin 2014. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
von der Maase H, Sengelov L, Roberts JT,
Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A and Arning
M: Long-term survival results of a randomized trial comparing
gemcitabine plus cisplatin, with methotrexate, vinblastine,
doxorubicin, plus cisplatin in patients with bladder cancer. J Clin
Oncol. 23:4602–4608. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shirodkar SP and Lokeshwar VB: Potential
new urinary markers in the early detection of bladder cancer. Curr
Opin Urol. 19:488–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim WJ and Bae SC: Molecular biomarkers in
urothelial bladder cancer. Cancer Sci. 99:646–652. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Witjes JA, Compérat E, Cowan NC, De Santis
M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG and Sherif A;
European Association of Urology, : EAU guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2013
guidelines. Eur Urol. 65:778–792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Okudan N, Belviranlı M, Gökbel H, Oz M and
Kumak A: Protective effects of curcumin supplementation on
intestinal ischemia reperfusion injury. Phytomedicine. 20:844–848.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan Z, Jing H, Yao J, Li Y, Hu X, Shao H,
Shen G, Pan J, Luo F and Tian X: The protective effects of curcumin
on experimental acute liver lesion induced by intestinal
ischemia-reperfusion through inhibiting the pathway of NF-κB in a
rat model. Oxid Med Cell Longev. 2014:1916242014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Anand P, Sundaram C, Jhurani S,
Kunnumakkara AB and Aggarwal BB: Curcumin and cancer: An ‘old-age’
disease with an ‘age-old’ solution. Cancer Lett. 267:133–164. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
Busch C, Cheng L, Kiemeney L, Kriegmair M, Montironi R, Murphy WM,
et al: Bladder cancer: Epidemiology, staging and grading, and
diagnosis. Urology. 66 6 Suppl 1:S4–S34. 2005. View Article : Google Scholar
|
|
10
|
Nargund VH, Tanabalan CK and Kabir MN:
Management of non-muscle-invasive (superficial) bladder cancer.
Semin Oncol. 39:559–572. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chaffer CL, Brennan JP, Slavin JL, Blick
T, Thompson EW and Williams ED: Mesenchymal-to-epithelial
transition facilitates bladder cancer metastasis: Role of
fibroblast growth factor receptor-2. Cancer Res. 66:11271–11278.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jain SK, Gill MS, Pawar HS and Suresh S:
Novel curcumin diclofenac conjugate enhanced curcumin
bioavailability and efficacy in streptococcal cell wall-induced
arthritis. Indian J Pharm Sci. 76:415–22. 2014.PubMed/NCBI
|
|
13
|
Shetty D, Kim YJ, Shim H and Snyder JP:
Eliminating the heart from the curcumin molecule: Monocarbonyl
curcumin mimics (MACs). Molecules. 20:249–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Manju V and Nalini N: Chemopreventive
efficacy of ginger, a naturally occurring anticarcinogen during the
initiation, post-initiation stages of 1, 2
dimethylhydrazine-induced colon cancer. Clin Chim Acta. 358:60–67.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang CL, Liu YY, Ma YG, Xue YX, Liu DG,
Ren Y, Liu XB, Li Y and Li Z: Curcumin blocks small cell lung
cancer cells migration, invasion, angiogenesis, cell cycle and
neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One.
7:e379602012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
García-Niño WR, Tapia E, Zazueta C,
Zatarain-Barrón ZL, Hernández-Pando R, Vega-García CC and
Pedraza-Chaverrí J: Curcumin pretreatment prevents potassium
dichromate-induced hepatotoxicity, oxidative stress, decreased
respiratory complex I activity, and membrane permeability
transition pore opening. Evid Based Complement Alternat Med.
2013:4246922013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jana S, Rudra DS, Paul S and Snehasikta S:
Curcumin delays endometriosis development by inhibiting MMP-2
activity. Indian J Biochem Biophys. 49:342–348. 2012.PubMed/NCBI
|
|
18
|
Jana S, Paul S and Warnakar SS: Curcumin
as anti-endometriotic agent: Implication of MMP-3 and intrinsic
apoptotic pathway. Biochem Pharmacol. 83:797–804. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kang Y, Hu W, Bai E, Zheng H, Liu Z, Wu J,
Jin R, Zhao C and Liang G: Curcumin sensitizes human gastric cancer
cells to 5-fluorouracil through inhibition of the NFκB
survival-signaling pathway. Onco Targets Ther. 9:7373–7384. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tong W, Wang Q, Sun D and Suo J: Curcumin
suppresses colon cancer cell invasion via AMPK-induced inhibition
of NF-κB, uPA activator and MMP9. Oncol Lett. 12:4139–4146.
2016.PubMed/NCBI
|
|
21
|
Gong G, Pan Q, Wang K, Wu R, Sun Y and Lu
Y: Curcumin-incorporated albumin nanoparticles and its tumor image.
Nanotechnology. 26:0456032015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang GM, Xie WY, Wang HS, Du J, Wu BP, Xu
W, Liu HF, Xiao P, Liu ZG, Li HY, et al: Curcumin combined with
FAPαc vaccine elicits effective antitumor response by targeting
indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in
melanoma. Oncotarget. 6:25932–25942. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cao F, Liu T, Xu Y, Xu D and Feng S:
Curcumin inhibits cell proliferation and promotes apoptosis in
human osteoclastoma cell through MMP-9, NF-κB and JNK signaling
pathways. Int J Clin Exp Pathol. 8:6037–6045. 2015.PubMed/NCBI
|
|
24
|
Li ZC, Zhang LM, Wang HB, Ma JX and Sun
JZ: Curcumin inhibits lung cancer progression and metastasis
through induction of FOXO1. Tumor Biol. 35:111–116. 2014.
View Article : Google Scholar
|
|
25
|
Wang Q, Qu C, Xie F, Chen L, Liu L, Liang
X, Wu X, Wang P and Meng Z: Curcumin suppresses
epithelial-to-mesenchymal transition and metastasis of pancreatic
cancer cells by inhibiting cancer-associated fibroblasts. Am J
Cancer Res. 7:125–133. 2017.PubMed/NCBI
|
|
26
|
Leu TH, Su SL, Chuang YC and Maa MC:
Direct inhibitory effect of curcumin on Src and focal adhesion
kinase activity. Biochem Pharmacol. 66:2323–2331. 2003. View Article : Google Scholar : PubMed/NCBI
|
